Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: A comparative study.

被引：0
|
作者：
Loizzi, V
Cormio, G
Di Vagno, G
Resta, L
Cazzolla, A
Di Gilio, A
Cuccovillo, A
Selvaggi, L
机构：
[1] Univ Bari, Dept Ob Gyn, Bari, Italy
[2] Univ Bari, Dept Pathol, Bari, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5117
引用
收藏
页码：478S / 478S
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy for epithelial ovarian cancer - role of apoptosis
    Dutta, T
    Sharma, H
    Kumar, L
    Dinda, AK
    Kumar, S
    Bhatla, N
    Singh, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (04) : 427 - 435
  • [42] Neoadjuvant chemotherapy for epithelial ovarian cancer—role of apoptosis
    Tania Dutta
    Himani Sharma
    Lalit Kumar
    A. K. Dinda
    Sunesh Kumar
    Neerja Bhatla
    Neeta Singh
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 427 - 435
  • [43] Is there a role for neoadjuvant chemotherapy in stage IV endometrial cancer?
    Rauh, L.
    Duska, L.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 162 - 162
  • [44] Cytoreductive surgery following neoadjuvant chemotherapy in patients with initial unresectable stage IV ovarian cancer
    Hogen, Liat
    Tanen, Adina
    May, Taymaa
    Avery, Lisa
    Ferguson, Sarah
    Laframboise, Stephane
    Bouchard-Fortier, Genevieve
    Bernardini, Marcus
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S132 - S132
  • [45] Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer
    Vergote, Ignace
    Trope, Claes G.
    Amant, Frederic
    Ehlen, Tom
    Reed, Nick S.
    Casado, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4076 - 4078
  • [46] Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
    Gao, Yan
    Li, Yuan
    Zhang, Chunyu
    Han, Jinsong
    Liang, Huamao
    Zhang, Kun
    Guo, Hongyan
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (01) : 85
  • [47] Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
    Yan Gao
    Yuan Li
    Chunyu Zhang
    Jinsong Han
    Huamao Liang
    Kun Zhang
    Hongyan Guo
    Journal of Ovarian Research, 12
  • [48] A phase II study evaluating carboplatin/paclitaxel/ pembrolizumab among newly diagnosed stage III/IV epithelial ovarian cancer patients receiving neoadjuvant chemotherapy followed by olaparib/pembrolizumab maintenance
    Kincaid, Kaitlyn
    Ketch, Peter
    North, Alexandra
    Chambers, Mary
    Wilbanks, Anna
    Moore, Jennah
    Dover, Bailee
    Lyle, Kathryn
    Bae, Sejong
    Leath, Charles
    Arend, Rebecca
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S292 - S292
  • [49] Identification of new prognostic factors in FIGO stage III and IV epithelial ovarian cancer
    Kolev, V.
    Zivanovic, O.
    Dottino, J.
    Levine, D. A.
    Barakat, R. R.
    Chi, D. S.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S134 - S134
  • [50] Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer
    Forde, Gareth K.
    Chang, Jenny
    Ziogas, Argyrios
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 397 - 406
12345